Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the Cancer and Leukemia Group B 9182 study.
- Citation:
- J Clin Oncol vol 17 (8) 2506-13
- Year:
- 1999
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P W Kantoff S Halabi M Conaway J Picus J Kirshner V Hars D Trump E P Winer N J Vogelzang
- Networks:
- Study
- Alliance-9182
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Aged, Anti-Inflammatory Agents, Antineoplastic Agents, Drug Therapy, Combination, Humans, Hydrocortisone, Male, Mitoxantrone, Neoplasm Metastasis, Pain, Prognosis, Proportional Hazards Models, Prostatic Neoplasms, Quality of Life, Treatment Failure